leukocyte alkaline phosphatase (LAP)
Jump to navigation
Jump to search
Indications
- principal utility is in distinguishing chronic myelogenous leukemia (CML) from leukemoid reactions & other myelo- proliferative disorders
Reference interval
- 15-40 mg of phosphorous liberated/hour per 10E10 cells
- score 13-130 per 100 neutrophils & band forms (score determined by individual laboratory)
Increases
- clinical disorders
- pharmaceutical agents
* In remission of CML, LAP may return to normal & may be elevated with CML in blast crisis[3]
alkaline phosphatase-L (liver/kidney/bone) or tissue-nonspecific alkaline phosphatase
Decreases
(Low or absent in)
- clinical disorders
- chronic myeloid leukemia (CML)*
- paroxysmal nocturnal hemoglobinuria (PNH)
- infectious mononucleosis
- aplastic anemia [1, 2]
- sideroblastic anemia
- idiopathic thrombocytopenic purpura (ITP)
- connective tissue disorders
- acute myeloid leukemia
- acute monocytic leukemia
- cirrhosis
- congestive heart failure with passive liver congestion
- diabetes mellitus
- gout
- pernicious anemia (increases after treatment)
- hereditary hypophosphatemia
- sarcoidosis
- pharmaceutical agents
- chemical interference
Methods
Specimen
- finger-stick preferred
- collect venous blood in heparin or oxalate; do NOT use EDTA
- fix slides in formalin/methanol within 30 minutes or keep in dessicator until fixed
More general terms
Additional terms
References
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 433, 435
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
- ↑ 3.0 3.1 3.2 Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995